Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Days.
The item "Defensive-Intrval-Ratio" stands at 339.73 days as of 09/30/2025.
As of the end of Eisai Co. Ltd.'s second quarter, the item "Defensive Intrval Ratio" stands at 339.73 Days. This represents an increase of 4.55 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.61 percent compared to the value the year prior.
The 1 year change in percent is 8.61.
The 3 year change in percent is 16.87.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Defensive Intrval Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Defensive Intrval Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Defensive Intrval Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Defensive Intrval Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Defensive Intrval Ratio | 280,205,508,085.11 |